Literature DB >> 1351363

Direct DNA analysis of fragile X syndrome in Spanish pedigrees.

I Tejada1, E Mornet, V Biancalana, I Oberlé, J Boué, J L Mandel, A Boué.   

Abstract

Eleven complete Spanish pedigrees with fragile X syndrome were analysed by Southern blotting with the DNA probe StB12.3 previously isolated and described by Oberlé et al. [1991]. This probe allowed the direct detection of affected males and carrier females and was able to distinguish between normal males and normal transmitting males (NTMs). One hundred and twenty three individuals were analyzed, 115 from the pedigrees and 8 from the general population. Five mosaic cases were found (4 males and one female) showing both the premutation and the full mutation. One half of the females with the full mutation were mentally retarded but no female with mental retardation carried the premutated pattern, suggesting that the absence of the full mutation in females is a very good criterion for pre-or postnatal diagnosis of normal mental status.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351363     DOI: 10.1002/ajmg.1320430144

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  4 in total

1.  Identification by molecular diagnosis of mosaic Turner's syndrome in an obligate carrier female for fragile X syndrome.

Authors:  M I Tejada; E Mornet; E Tizzano; M Molina; M Baiget; A Boue
Journal:  J Med Genet       Date:  1994-01       Impact factor: 6.318

2.  Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a small number of founder chromosomes.

Authors:  C Oudet; E Mornet; J L Serre; F Thomas; S Lentes-Zengerling; C Kretz; C Deluchat; I Tejada; J Boué; A Boué
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

3.  Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models.

Authors:  Eva García-Alegría; Berta Ibáñez; Mónica Mínguez; Marisa Poch; Alberto Valiente; Arantza Sanz-Parra; Cristina Martinez-Bouzas; Elena Beristain; Maria-Isabel Tejada
Journal:  RNA       Date:  2007-05       Impact factor: 4.942

4.  Molecular testing for fragile X: analysis of 5062 tests from 1105 fragile X families--performed in 12 clinical laboratories in Spain.

Authors:  María-Isabel Tejada; Guillermo Glover; Francisco Martínez; Miriam Guitart; Yolanda de Diego-Otero; Isabel Fernández-Carvajal; Feliciano J Ramos; Concepción Hernández-Chico; Elizabet Pintado; Jordi Rosell; María-Teresa Calvo; Carmen Ayuso; María-Antonia Ramos-Arroyo; Hiart Maortua; Montserrat Milà
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.